Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).
D000284:Administration, Oral; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002214:Capsules; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002214:Capsules; D004338:Drug Combinations; D006834:Hydrazines; D004295:Dihydroxyphenylalanine